Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Dyne Therapeutics

Dyne Therapeutics is developing nucleic acid therapies for rare diseases.

Dyne Therapeutics logo
Website - Coming Soon
  • Romesh R. Subramanian, PhD Chief Scientific Officer
  • Mo Qatanani, PhD Senior Director
  • Tim Weeden, BS Associate Director
  • Cody Desjardins, PhD Senior Scientist